FindTrial
Sign In

How many people with diabetic peripheral neuropathy have cardiac autonomic neuropathy?

AUTONOMIC NEUROPATHY IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY: A CROSS SECTIONAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/10/021742
Enrollment
233
Registered
2019-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Control Intervention1: nil: nil

Sponsors

KASTURBA MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic peripheral neuropathy(with h/o diabetes and symptoms and/or signs of diabetic peripheral neuropathy), NCV

Exclusion criteria

Exclusion criteria: Patients taking beta blockers, clonidine, prazosin, steroids, ohenytoin, cisplatin, vincristine, amiodarone, fluoroquinolones, metronidazole, isoniazid, nitrofurantoin chronic kidney disease h/o significant alcohol intake vitamin b12 deficiency HIV Severe systemic disease(cardiac, pulmonary, malignancy) Unstable patient(A/E COPD, Bronchial asthma, severe HTN, ECG s/o myocardial ischemia or infarct)

Design outcomes

Primary

MeasureTime frame
Prevalence of autonomic neuropathy in patients who have diabetic peripheral neuropathyTimepoint: 3 years—

Secondary

MeasureTime frame
Autonomic dysfunction stages correlation with various types of diabetic peripheral neuropathy and their severity Autonomic dysfunction correlation with hypoglycemia and neuroglycopeniaTimepoint: 2 years—

Countries

India

Contacts

Public ContactPOONAM ASHOK KAMATH

KMC, MANIPAL

vsagar33@yahoo.com9880083580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026